serena williams using glp 1 Inside Williams' 14kg weight loss: How GLP-1 injections work and 5 side effects to know Serena Williams reveals she's been

FDA determined on December 19, 2024 that the tirzepatide injection shortage was resolved, and on February 21, 2025 that the semaglutide injection shortage was resolved

Criteria, preferred drugs, and prior authorization requirements vary within each state

Beyond glucose control, GLP-1 significantly affects satiety and gastric function

Digestive side effects of GLP-1s include nausea, bloating, vomiting, constipation, diarrhea, belching, indigestion and more, outlined in Figure 3 of this article and Table 2 of this article

Use the vitamin and nutrients summary report to help you identify potential weak spots that are personal to your genes

Klebanoff: Most Medicare beneficiaries are covered for semaglutide and tirzepatide for diabetes